Recombinant Human IGFL1 Protein，His

IGFL1 (Insulin-like Growth Factor-Like 1) is a member of the insulin-like growth factor family, which plays a crucial role in growth and development by mediating various cellular processes such as proliferation, differentiation, and apoptosis. This protein has garnered attention due to its potential implications in both physiological and pathological conditions, including muscle hypertrophy, cancer, and metabolic diseases. The study of recombinant IGFL1 has become increasingly important as it provides a means to understand its biological functions and therapeutic potential. By expressing IGFL1 in a recombinant system, researchers can obtain sufficient quantities for rigorous analysis, including binding studies and functional assays. Additionally, recombinant IGFL1 allows for the exploration of its interactions with other growth factors and receptors, shedding light on its role in signaling pathways. Understanding these mechanisms may lead to novel therapeutic strategies for conditions where IGFL1 is implicated. Furthermore, the investigation of IGFL1 can contribute to the development of biomarker diagnostics and targeted treatments for diseases such as cancer, where its altered expression may signify disease progression or therapeutic response. Overall, the research on recombinant IGFL1 not only enhances our understanding of fundamental biological processes but also opens new avenues for clinical applications in regenerative medicine and oncology.